Sweden · Delayed Price · Currency is SEK Enzymatica AB Statistics
Total Valuation
Enzymatica AB has a market cap or net worth of SEK 529.16 million. The enterprise value is 530.18 million.
| Market Cap | 529.16M |
| Enterprise Value | 530.18M |
Important Dates
The last earnings date was Thursday, July 16, 2026.
| Earnings Date | Jul 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Enzymatica AB has 242.74 million shares outstanding. The number of shares has increased by 6.03% in one year.
| Current Share Class | 242.74M |
| Shares Outstanding | 242.74M |
| Shares Change (YoY) | +6.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.14% |
| Owned by Institutions (%) | 13.34% |
| Float | 106.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.19 |
| PB Ratio | 5.39 |
| P/TBV Ratio | 15.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.14.
| Current Ratio | 2.45 |
| Quick Ratio | 1.47 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.48 |
| Interest Coverage | -603.58 |
Financial Efficiency
Return on equity (ROE) is -37.90% and return on invested capital (ROIC) is -21.67%.
| Return on Equity (ROE) | -37.90% |
| Return on Assets (ROA) | -19.99% |
| Return on Invested Capital (ROIC) | -21.67% |
| Return on Capital Employed (ROCE) | -40.70% |
| Weighted Average Cost of Capital (WACC) | 2.10% |
| Revenue Per Employee | 2.47M |
| Profits Per Employee | -2.18M |
| Employee Count | 21 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.40 |
Taxes
In the past 12 months, Enzymatica AB has paid 719,000 in taxes.
| Income Tax | 719,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.34% in the last 52 weeks. The beta is -0.38, so Enzymatica AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.38 |
| 52-Week Price Change | -25.34% |
| 50-Day Moving Average | 2.52 |
| 200-Day Moving Average | 2.23 |
| Relative Strength Index (RSI) | 38.12 |
| Average Volume (20 Days) | 78,991 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Enzymatica AB had revenue of SEK 51.93 million and -45.85 million in losses. Loss per share was -0.19.
| Revenue | 51.93M |
| Gross Profit | 29.96M |
| Operating Income | -44.67M |
| Pretax Income | -45.13M |
| Net Income | -45.85M |
| EBITDA | -42.27M |
| EBIT | -44.67M |
| Loss Per Share | -0.19 |
Balance Sheet
The company has 13.15 million in cash and 14.17 million in debt, with a net cash position of -1.02 million or -0.00 per share.
| Cash & Cash Equivalents | 13.15M |
| Total Debt | 14.17M |
| Net Cash | -1.02M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 98.22M |
| Book Value Per Share | 0.40 |
| Working Capital | 21.54M |
Cash Flow
In the last 12 months, operating cash flow was -29.54 million and capital expenditures -231,000, giving a free cash flow of -29.77 million.
| Operating Cash Flow | -29.54M |
| Capital Expenditures | -231,000 |
| Depreciation & Amortization | 2.40M |
| Net Borrowing | -2.08M |
| Free Cash Flow | -29.77M |
| FCF Per Share | -0.12 |
Margins
Gross margin is 57.69%, with operating and profit margins of -86.01% and -88.30%.
| Gross Margin | 57.69% |
| Operating Margin | -86.01% |
| Pretax Margin | -86.91% |
| Profit Margin | -88.30% |
| EBITDA Margin | -81.39% |
| EBIT Margin | -86.01% |
| FCF Margin | n/a |
Dividends & Yields
Enzymatica AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.03% |
| Shareholder Yield | -6.03% |
| Earnings Yield | -8.67% |
| FCF Yield | -5.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |